Home›Pharmacies›NovoCare Pharmacy

NovoCare Pharmacy

Manufacturer-direct pharmacyNo FDA actions found

Novo Nordisk's self-pay pharmacy channel for Wegovy, launched 2025-03-05. CenterWell Pharmacy fulfills and delivers its home shipments. Novo opened it to Hims & Hers, LifeMD and Ro in April 2025 and later to WeightWatchers.

Legal name: NovoCare Pharmacy (Novo Nordisk); home shipments dispensed by CenterWell Pharmacy

Makes or dispenses: semaglutide

Telehealth brands that use NovoCare Pharmacy

Same pharmacy, different provider: these brands fill prescriptions through the same pharmacy but differ in price, clinical support, and billing. Their cheapest ongoing GLP-1 prices run from $149 to $298/mo.

78
Hims & Hers
Fills: Wegovy · named by the brand
GLP-1: $149 month 1 → $149/mo after
Visit Hims & Hers
77
Ro
Fills: Wegovy · named by the brand
GLP-1: $188 month 1 → $298/mo after
Visit Ro
68
LifeMD
Fills: Wegovy · named by the brand
GLP-1: $188 month 1 → $298/mo after
Visit LifeMD
67
Shed
Fills: Wegovy · named by the brand
GLP-1: $199 month 1 → $159/mo after
Visit Shed
60
WeightWatchers
Fills: Wegovy · patient-reported
Visit WeightWatchers

FDA and regulatory record

We didn't find FDA warning letters, Form 483s, or recalls for NovoCare Pharmacy as of 2026-09-26. State board actions aren't always published centrally, so you can also check your state board of pharmacy.

Questions about NovoCare Pharmacy

Which telehealth companies use NovoCare Pharmacy?

▾

Among the brands we track: Hims & Hers, Ro, LifeMD, Shed, WeightWatchers. Some of these links come from patient reports rather than the brand itself; they're marked on this page.

What kind of pharmacy is NovoCare Pharmacy?

▾

NovoCare Pharmacy is listed as: manufacturer-direct pharmacy. 503A pharmacies compound medication for individual patient prescriptions under state board oversight; 503B outsourcing facilities register with the FDA and follow federal manufacturing standards (CGMP).

Has NovoCare Pharmacy received FDA warning letters?

▾

We didn't find FDA warning letters, Form 483s, or recalls for NovoCare Pharmacy in FDA's public records as of 2026-09-26. That isn't a guarantee; state board actions aren't always published centrally.

Sources

Researched 2026-09-26.